Companies similar to INTELLIA THERAPEUTICS INC (NTLA)
Health Care · NASDAQ
INTELLIA THERAPEUTICS INC (NTLA)'s closest peers include CRISPR THERAPEUTICS AG (CRSP), EDITAS MEDICINE INC (EDIT), BEAM THERAPEUTICS INC (BEAM) and Vertex Pharmaceuticals (VRTX). This peer set is drawn from NTLA's enriched company profile and is informational only — not financial advice.
Similar companies
-
CRISPR THERAPEUTICS AGCRSPHealth Care
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and…
$48.57 (as of 2026-07-16) · market cap $4.7B
-
EDITAS MEDICINE INCEDITHealth Care
A pioneering CRISPR gene editing company developing in vivo therapies for genetic diseases, with lead candidate EDIT-401 targeting hyperlipidemia through LDL…
$2.88 (as of 2026-07-16) · market cap $435M
-
BEAM THERAPEUTICS INCBEAMHealth Care
Beam Therapeutics is developing base editing medicines—a precision genetic cure approach—for serious inherited diseases like sickle cell disease and rare…
$28.39 (as of 2026-07-16) · market cap $2.9B
-
Vertex PharmaceuticalsVRTXHealth Care
Vertex Pharmaceuticals develops transformative medicines for serious genetic diseases, with a dominant pipeline anchored in cystic fibrosis treatments and…
$486.03 (as of 2026-07-16) · market cap $121.8B
Not quite? Describe exactly what you want →
Peers are drawn from NTLA's enriched profile (the same similarity signal the chat uses for "companies like NTLA"). See the full profile: INTELLIA THERAPEUTICS INC (NTLA).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.